Targeting immunotherapy for bladder cancer by using anti-CD3 × CD155 bispecific antibody

To investigate whether CD155 is an attractive target for T cell-mediated immunotherapy against human bladder cancer, we examined the novel bispecific antibody anti-CD3 x anti-CD155 (CD155Bi-Ab) for its ability to redirect activated T cells (ATCs) to target bladder cancer cells was examined. Expressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Wanru, Ma, Juan, Lei, Ting, Zhao, Man, Zhang, Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775611/
https://www.ncbi.nlm.nih.gov/pubmed/31602268
http://dx.doi.org/10.7150/jca.29937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775611/
https://www.ncbi.nlm.nih.gov/pubmed/31602268
http://dx.doi.org/10.7150/jca.29937

Ejemplares similares